Ambrx Biopharma, Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q3 2022 to Q3 2023

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Ambrx Biopharma, Inc. quarterly Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q3 2022 to Q3 2023.
  • Ambrx Biopharma, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2023 was 62.3M shares, a 61.2% increase year-over-year.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 62.3M +23.6M +61.2% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q3 2022 38.6M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.